期刊文献+
共找到7篇文章
< 1 >
每页显示 20 50 100
Decoding the evolution and transmissions of the novel pneumonia coronavirus(SARS-CoV-2/HCoV-19)using whole genomic data 被引量:29
1
作者 Wen-Bin Yu Guang-Da Tang +1 位作者 Li Zhang Richard T.Corlett 《Zoological Research》 SCIE CAS CSCD 2020年第3期247-257,共11页
The outbreak of COVID-19 started in mid-December2019 in Wuhan, China. Up to 29 February 2020,SARS-CoV-2(HCoV-19/2019-nCoV) had infected more than 85 000 people in the world. In this study,we used 93 complete genomes o... The outbreak of COVID-19 started in mid-December2019 in Wuhan, China. Up to 29 February 2020,SARS-CoV-2(HCoV-19/2019-nCoV) had infected more than 85 000 people in the world. In this study,we used 93 complete genomes of SARS-CoV-2 from the GISAID EpiFlu TM database to investigate the evolution and human-to-human transmissions of SARS-CoV-2 in the first two months of the outbreak.We constructed haplotypes of the SARS-CoV-2 genomes, performed phylogenomic analyses and estimated the potential population size changes of the virus. The date of population expansion was calculated based on the expansion parameter tau(τ)using the formula t=τ/2 u. A total of 120 substitution sites with 119 codons, including 79 non-synonymous and 40 synonymous substitutions, were found in eight coding-regions in the SARS-CoV-2 genomes.Forty non-synonymous substitutions are potentially associated with virus adaptation. No combinations were detected. The 58 haplotypes(31 found in samples from China and 31 from outside China)were identified in 93 viral genomes under study and could be classified into five groups. By applying the reported bat coronavirus genome(bat-RaTG13-CoV)as the outgroup, we found that haplotypes H13 and H38 might be considered as ancestral haplotypes,and later H1 was derived from the intermediate haplotype H3. The population size of the SARS-CoV-2 was estimated to have undergone a recent expansion on 06 January 2020, and an early expansion on 08 December 2019. Furthermore,phyloepidemiologic approaches have recovered specific directions of human-to-human transmissions and the potential sources for international infected cases. 展开更多
关键词 COVID-19 hcov-19 SARS-CoV-2 Novel pneumonia outbreak Human-to-human transmission Phyloepidemiology
下载PDF
Zoonotic origins of human coronavirus 2019(HCoV-19/SARS-CoV-2):why is this work important? 被引量:12
2
作者 Gary Wong Yu-Hai Bi +3 位作者 Qi-Hui Wang Xin-Wen Chen Zhi-Gang Zhang Yong-Gang Yao 《Zoological Research》 SCIE CAS CSCD 2020年第3期213-219,共7页
The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by infection with human coronavirus 2019 (HCoV-19/SARS-CoV-2/2019-nCoV), is a global threat to the human population. Here, we briefly summarize the a... The ongoing pandemic of coronavirus disease 2019 (COVID-19), caused by infection with human coronavirus 2019 (HCoV-19/SARS-CoV-2/2019-nCoV), is a global threat to the human population. Here, we briefly summarize the available data for the zoonotic origins of HCoV-19, with reference to the other two epidemics of highly virulent coronaviruses, SARSCoV and MERS-CoV, which cause severe pneumonia in humans. We propose to intensify future efforts for tracing the origins of HCoV-19, which is a very important scientific question for the control and prevention of the pandemic. 展开更多
关键词 ORIGIN why is this work important hcov-19/SARS-CoV-2 Zoonotic origins of human coronavirus 2019
下载PDF
貂源冠状病毒与2019新型冠状病毒的遗传进化关系 被引量:1
3
作者 杨艳玲 程世鹏 任林柱 《中国动物检疫》 CAS 2020年第4期21-26,共6页
为进一步明确貂源冠状病毒与新型人冠状病毒HCoV-19的遗传进化关系,比较了NCBI上公布的3株水貂冠状病毒、5株雪貂冠状病毒以及人冠状病毒HCoV-19和SARS-Cov的全基因组、ORF1a、ORF1ab和病毒表面蛋白Spike的序列同源性,分析了其遗传进化... 为进一步明确貂源冠状病毒与新型人冠状病毒HCoV-19的遗传进化关系,比较了NCBI上公布的3株水貂冠状病毒、5株雪貂冠状病毒以及人冠状病毒HCoV-19和SARS-Cov的全基因组、ORF1a、ORF1ab和病毒表面蛋白Spike的序列同源性,分析了其遗传进化关系,以及组成病毒的结构蛋白和非结构蛋白的种类、基因位置及氨基酸数量。结果显示:貂源冠状病毒与新型冠状病毒HCoV-19全基因组、ORF1a、ORF1ab、Spike蛋白的相似性分别为68%、46.96%、52.44%、47.36%;貂源冠状病毒与HCoV-19不属于同一分支,且亲缘关系较远;同时,貂源冠状病毒与HCoV-19全基因组在蛋白组成、氨基酸数量、基因位置上均存在显著差异。结果表明,貂源冠状病毒与新型冠状病毒HCoV-19不是同一种冠状病毒,此次在人群中流行的新型冠状病毒HCoV-19由貂源冠状病毒重组而成的可能性很小,因此可初步排除HCoV-19来源于水貂和雪貂的可能性。 展开更多
关键词 水貂冠状病毒 新型冠状病毒(hcov-19) 基因组 遗传进化关系
下载PDF
COVID-19-like symptoms observed in Chinese tree shrews infected with SARS-CoV-2 被引量:21
4
作者 Ling Xu Dan-Dan Yu +10 位作者 Yu-Hua Ma Yu-Lin Yao Rong-Hua Luo Xiao-Li Feng Hou-Rong Cai Jian-Bao Han Xue-Hui Wang Ming-Hua Li Chang-Wen Ke Yong-Tang Zheng Yong-Gang Yao 《Zoological Research》 SCIE CAS CSCD 2020年第5期517-526,共10页
Thecoronavirusdisease2019(COVID-19)pandemic continues to pose a global threat to the human population. Identifying animal species susceptible to infection with the SARS-CoV-2/HCoV-19 pathogen is essential for controll... Thecoronavirusdisease2019(COVID-19)pandemic continues to pose a global threat to the human population. Identifying animal species susceptible to infection with the SARS-CoV-2/HCoV-19 pathogen is essential for controlling the outbreak and for testing valid prophylactics or therapeutics based on animal model studies. Here,different aged Chinese tree shrews(adult group, 1 year old;old group, 5–6 years old), which are close relatives to primates, were infected with SARS-CoV-2. X-ray, viral shedding, laboratory, and histological analyses were performed on different days postinoculation(dpi). Results showed that Chinese tree shrews could be infected by SARS-CoV-2. Lung infiltrates were visible in X-ray radiographs in most infected animals. Viral RNA was consistently detected in lung tissues from infected animals at 3,5, and 7 dpi, along with alterations in related parameters from routine blood tests and serum biochemistry, including increased levels of aspartate aminotransferase(AST) and blood urea nitrogen(BUN). Histological analysis of lung tissues from animals at 3 dpi(adult group) and 7 dpi(old group) showed thickened alveolar septa and interstitial hemorrhage. Several differences were found between the two different aged groups in regard to viral shedding peak. Our results indicate that Chinese tree shrews have the potential to be used as animal models for SARS-CoV-2 infection. 展开更多
关键词 SARS-CoV-2/hcov-19 Treeshrews Animal model SUSCEPTIBILITY COVID-19
下载PDF
抗新型冠状病毒2019-nCoV新药的研发 被引量:5
5
作者 刘奇 夏帅 姜世勃 《中国临床药理学与治疗学》 CAS CSCD 2020年第3期241-245,共5页
2019年底,湖北武汉暴发了2019新型冠状病毒感染疾病(COVID-19),并快速在全国蔓延,且在多个国家发现病例。其感染病例和死亡病例在短时间内快速超过重症急性呼吸综合征(SARS),给中国带来了不可估量的损失。中国科研人员在短时间内,快速... 2019年底,湖北武汉暴发了2019新型冠状病毒感染疾病(COVID-19),并快速在全国蔓延,且在多个国家发现病例。其感染病例和死亡病例在短时间内快速超过重症急性呼吸综合征(SARS),给中国带来了不可估量的损失。中国科研人员在短时间内,快速锁定病原体为2019-nCoV(或hCoV-19或SARS-CoV-2),并且在不同层面开展了相关抗病毒药物的研发工作。本文介绍了抗2019-nCoV新药研发的现状。同时,鉴于突发病原体的药物研发过程相对迟缓,我们建议对于潜在流行可能性的病原体,其药物研发要具有前瞻性,国家层面要推进广谱药物的研发和临床试验,以应对可能出现的疫情风险。 展开更多
关键词 新型冠状病毒 2019-nCoV hcov-19 SARS-CoV-2 药物研发 广谱
下载PDF
关于新型冠状病毒命名的思考与建议 被引量:10
6
作者 张冬梅 姜世勃 +23 位作者 石正丽 谭文杰 卢洪洲 曹彬 张文宏 刘叔文 钟劲 肖庚富 谢幼华 邓凯 赵金存 杨子峰 宋敬东 陆路 黄竞荷 应天雷 王乔 施莽 徐建青 安静 鲁凤民 高福 舒跃龙 郭德银 《中国科技术语》 2020年第2期5-10,共6页
2019年12月,一种由新型冠状病毒(2019-nCoV)引起的病毒性肺炎开始在武汉暴发流行。2020年2月11日,世界卫生组织(WHO)将新型冠状病毒肺炎命名为COVID-19(冠状病毒病2019),国际病毒分类学委员会(ICTV)的冠状病毒研究小组(CSG)建议把新型... 2019年12月,一种由新型冠状病毒(2019-nCoV)引起的病毒性肺炎开始在武汉暴发流行。2020年2月11日,世界卫生组织(WHO)将新型冠状病毒肺炎命名为COVID-19(冠状病毒病2019),国际病毒分类学委员会(ICTV)的冠状病毒研究小组(CSG)建议把新型冠状病毒命名为SARS-CoV-2(严重急性呼吸综合征冠状病毒2),既没有与疾病名称一致,也没有完全真实地显示该病毒本身的特征,因而立即引发关注和争议。基于COVID-19的病原学、流行病学和临床特征的基本信息,建议将新型冠状病毒命名为“人类冠状病毒2019”(human coronavirus 2019,简称HCoV-19)。文章回顾并评价了CSG的命名方法,指出他们使用基于基因序列信息进行病毒命名的方法并不合适,建议采用传统的联系疾病的病毒命名方法对具有明显疾病特点的病毒如2019-nCoV进行命名。 展开更多
关键词 冠状病毒 肺炎 2019新型冠状病毒 人类冠状病毒2019 冠状病毒病2019
下载PDF
氯喹抗新型冠状病毒的研究进展 被引量:2
7
作者 韩丽珠 边原 +6 位作者 肖洪涛 童荣生 闫峻峰 陈岷 舒永全 杨勇 尹琪楠 《华西药学杂志》 CAS CSCD 2021年第2期222-227,共6页
氯喹是一种廉价、高效、作用持久的抗疟药,亦是一个广泛的抗病毒药物。氯喹在体外和/或体内对HCoV-229E、SARS-CoV、HCoV-OC43、MERS-CoV均具有明显的抗病毒活性。最新研究表明:氯喹对SARS-CoV-2感染的细胞同样具有很强的作用,目前大量... 氯喹是一种廉价、高效、作用持久的抗疟药,亦是一个广泛的抗病毒药物。氯喹在体外和/或体内对HCoV-229E、SARS-CoV、HCoV-OC43、MERS-CoV均具有明显的抗病毒活性。最新研究表明:氯喹对SARS-CoV-2感染的细胞同样具有很强的作用,目前大量开展的临床试验也在不断证实氯喹的体内抗病毒活性。现对氯喹的抗人冠状病毒作用的研究进展进行综述,以期为氯喹抗新型冠状病毒肺炎的研究和应用提供参考。 展开更多
关键词 氯喹 hcov-229E SARS-COV hcov-OC43 MERS-CoV SARS-CoV-2 新型冠状病毒肺炎 抗病毒
原文传递
上一页 1 下一页 到第
使用帮助 返回顶部